TY  - JOUR
AU  - Anguita-Ruiz, Augusto
AU  - Pastor-Villaescusa, Belén
AU  - Leis, Rosaura
AU  - Bueno, Gloria
AU  - Hoyos, Raúl
AU  - Vázquez-Cobela, Rocío
AU  - Latorre-Millán, Miriam
AU  - Cañete, M Dolores
AU  - Caballero-Villarraso, Javier
AU  - Gil, Ángel
AU  - Cañete, Ramón
AU  - Aguilera, Concepción M
PY  - 2019
DO  - 10.3390/jcm8091471
SN  - 2077-0383
UR  - https://hdl.handle.net/10668/28151
T2  - Journal of clinical medicine
AB  - Metformin is a first-line oral antidiabetic agent that has shown additional effects in treating obesity and metabolic syndrome. Inter-individual variability in metformin response could be partially explained by the genetic component. Here, we aimed to...
LA  - en
KW  - SNP
KW  - clinical trials
KW  - metformin
KW  - obesity
KW  - pediatrics
KW  - pharmacogenetics
TI  - Common Variants in 22 Genes Regulate Response to Metformin Intervention in Children with Obesity: A Pharmacogenetic Study of a Randomized Controlled Trial.
TY  - research article
VL  - 8
ER  -